Skip Navigation
Skip to contents

Ann Lab Med.  2014 Sep;34(5):399-401. 10.3343/alm.2014.34.5.399.

Rapid Sequential Gain of ABL1 Kinase Domain Mutations with a Complex Karyotype in the Progression of Chronic Myelogenous Leukemia

Affiliations
  • 1Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea.
  • 2Hematologic Oncology Clinic, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
  • 3Department of Laboratory Medicine, Research Institute and Hospital, National Cancer Center, Goyang, Korea. finekong@gmail.com
  • 4Greencross Reference Laboratory, Yongin, Korea.

Abstract

No abstract available.


MeSH Terms

Base Sequence
Benzamides/therapeutic use
Bone Marrow/pathology
Female
Fusion Proteins, bcr-abl/*genetics
Humans
Karyotyping
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/*genetics
Middle Aged
Philadelphia Chromosome
Piperazines/therapeutic use
Protein Kinase Inhibitors/therapeutic use
Pyrimidines/therapeutic use
Sequence Analysis, DNA
Thiazoles/therapeutic use
Translocation, Genetic
Benzamides
Fusion Proteins, bcr-abl
Piperazines
Protein Kinase Inhibitors
Pyrimidines
Thiazoles
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr